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2002.—Airway function in health and disease as well as in
response to bronchospastic stimuli (i.e., irritants, allergens,
and inflammatory mediators) is controlled, in part, by cho-
linergic muscarinic receptor regulation of smooth muscle. In
particular, the dependence of airway smooth muscle contrac-
tion/relaxation on heterotrimeric G protein-coupled receptor
signaling suggests that these events underlie the responses
regulating airway function. Gq-containing G proteins are
proposed to be a prominent signaling pathway, and the
availability of knockout mice deficient of this subunit has
allowed for an investigation of its potential role in airway
function. Airway responses in Gq-deficient mice (activities
assessed by both tracheal tension and in vivo lung function
measurements) were attenuated relative to wild-type con-
trols. Moreover, ovalbumin sensitization/aerosol challenge of
Gq-deficient mice also failed to elicit an allergen-induced
increase in airway reactivity to methacholine. These findings
indicate that cholinergic receptor-mediated responses are
dependent on Gq-mediated signaling events and identify
Gq as a potential target of preventative/intervening thera-
pies for lung dysfunction.
G protein; gene knockout mice
AIRFLOW LIMITATIONS IN PATIENTS with pulmonary disease,
most notably chronic obstructive pulmonary disease
(COPD) (12, 13, 37) and asthma (27, 29), are controlled
by receptor-ligand interactions that signal through G
protein-coupled receptors. In particular, M3 and M2
muscarinic receptors on airway smooth muscle appear
to regulate bronchomotor responses (8), including the
demonstration that signaling through M3 receptors is
capable of eliciting contraction of smooth muscle (32),
whereas M2 receptors contribute to contraction by in-
hibiting the relaxation of smooth muscle (9). Specifi-
cally, acetylcholine released from parasympathetic
cholinergic nerves bind M3 receptors on the smooth
muscle, leading directly to contraction via a series of
intracellular signaling events that are dependent on
sustained increases in intracellular calcium and
smooth muscle myosin light chain phosphorylation/
activation (35). The responses elicited by cholinergic
receptor binding are dependent on the activation of
receptor-coupled heterotrimeric G proteins and the
subsequent generation of specific effector signaling
molecules such as phosphoinositol and diacylglycerol.
Among the four families of G proteins (Gi, Gs, Gq, G12)
(39), the M3 receptor preferentially couples to the Gq
family (6), whereas the M2 receptor preferentially cou-
ples to the Gi family (8).
The Gq family includes four members identified by
their -subunits as Gq, G11, G14, and G15/16 (40). These
proteins are functionally similar, yet multiple mem-
bers of the Gq family are usually coexpressed in the
same cells (40). This has led to several investigations
aimed at examining whether the various members of
the Gq family, most notably Gq and G11, display dis-
tinct functional coupling to receptors or whether they
are interchangeable with multiple receptors. For ex-
ample, Gq and G11 have comparable abilities to acti-
vate phospholipase C in transfected cell systems (21,
28), and Xu et al. (43) have demonstrated that Gq and
G11 promiscuously couple M3 receptors to mediate
identical calcium signaling responses in pancreatic and
submandibular gland cells. Furthermore, knockout
mice deficient for Gq and G11 exhibit functional redun-
dancy in craniofacial development and cardiomyocyte
proliferation in the fetus (31) and cardiomyocyte hy-
pertrophy in adults (38). Alternatively, distinct func-
tions of Gq and G11 following activation of 1-adreno-
receptors have been demonstrated in rat portal vein
myocytes (25), and the involvement of Gq, but not G11,
has been shown in G protein-deficient fibroblasts in
response to Pateurella multocida bacterial toxin (44).
Gene knockout mice deficient in the -subunit of Gq
(Gq/ mice) were utilized to determine the role of
this G protein in airway responsiveness. The data show
that mice deficient in Gq are hyporesponsive to cholin-
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ergic receptor activation. These responses are much
greater in whole animal studies than in isolated tra-
chea, suggesting that effects of the Gq deletion may
not be smooth muscle autonomous but instead affect
multiple cell types contributing to airway responsive-
ness in vivo. Furthermore, mice lacking Gq were un-
able to develop airway hyperresponsiveness (AHR) in
an allergen-induced model of increased airway reactiv-
ity. Together, these data demonstrate an important
role for Gq in the development of airway resistance and
AHR.
MATERIALS AND METHODS
Mice. The generation of Gq (30) knockout mice has been
previously described. Mice were maintained on a 129/Sv 
C57BL/6 crossbred background. All procedures were con-
ducted on mice 10–14 wk of age that were maintained in
microisolator cages housed in a specific pathogen-free animal
facility. The sentinel cages within this animal colony were
negative for viral antibodies and the presence of known
mouse pathogens. Protocols and studies involving animals
were conducted in accordance with National Institutes of
Health and Mayo Clinic Foundation guidelines.
Western blot analysis. Protein was extracted from tracheal
homogenates including epithelium, smooth muscle, and car-
tilage and subjected to SDS-PAGE (10% polyacrylamide).
Rabbit antisera specific for Gq, G11, and Gq/11 have been
described in Hepler et al. (16). We detected proteins (42
kDa) using the ECL Chemiluminescence Western Blotting
Detection Kit (Amersham, Piscataway, NJ) with a donkey
anti-rabbit IgG, horseradish peroxidase-linked secondary an-
tibody (Amersham).
Tissue preparation and measurement of isometric tension.
Measurement of mouse tracheal contractility was performed
as previously described (18). Briefly, mice (20–30 g) were
euthanized with 500 mg/kg pentobarbital sodium, and distal
segments of trachea containing six cartilaginous rings (con-
taining epithelium and cartilage) were rapidly removed and
placed, at room temperature, in modified Krebs-Henseleit
(KH) solution [(in mM) 116 NaCl, 4.7 KCl, 2.5 CaCl, 0.5
MgCl2, 25 NaHCO3/NaH2PO4, and 11 glucose] that was
continuously oxygenated (95% O2-5% CO2) to maintain a pH
of 7.4. No differences were observed in tissue wet weight
between the two groups. Excess tissue was subsequently
removed, and the tracheas were mounted longitudinally on
stainless steel rings in a 30-ml water-jacketed organ bath
(model 159920; Radnotti, Monrovia, CA) containing continu-
ously oxygenated modified KH maintained at 37°C with a
thermocirculator (model 50–1932; Harvard Apparatus, Hol-
liston, MA). We allowed the mounted tracheas to equilibrate
for 30 min before suspending them upright on glass hooks
under a tension of 0.8 g. Stable tension was achieved after
approximately five cycles of 15-min incubations, washings,
and readjustments of tension to 0.8 g. Changes in force were
measured isometrically with a force-displacement transducer
(Harvard Apparatus) and collected with a BIOPAC data-
acquisition unit and BIOPAC Acqknowledge software
(BIOPAC, Santa Barbara, CA). Once a stable tension was
established, the tracheal smooth muscle was depolarized
with KCl in KH solution at a final concentration of 50 mM.
Hyperosmotic KCl exposure was maintained until the iso-
metric force generated by the tracheal contraction reached a
plateau. The tracheas were then washed for two cycles to
achieve a stable resting tension before methacholine (MCh)
dose-response measurements. Increasing doses of MCh (109
M–104 M) were applied, allowing the isometric forces to
plateau. Active tension (i.e., tension generated above resting
tension) is reported as a percentage of the maximal tension
obtained with 104 M MCh.
Measurements of lung mechanics. Respiratory system me-
chanics were assessed in mice according to the method of
Gomes et al. (11). Mice were anesthetized with pentobarbital
sodium (50 mg/kg ip, Nembutal; Abbott, Chicago, IL). Tra-
cheas were surgically accessed through a ventral midline
incision and connected with a small animal ventilator (SAV,
FlexiVent; SCIREQ, Montreal, Quebec, Canada) via an 18-
gauge needle. Mice were subsequently paralyzed with doxa-
curium chloride (0.5 mg/kg) (Nuromax; Catalytica, Green-
ville, NC) and ventilated at a frequency of 150 breaths/min
and at a volume of 6 ml/kg. The mice expired passively
through the expiratory valve of the ventilator against a
positive end-expiratory pressure of 3 cmH2O. MCh aerosol
was generated with an in-line nebulizer (model 5500D; De-
Vilbiss, Somerset, PA) and administered directly through the
ventilator. We determined the resistive properties of the
lungs at constant volume using forced oscillations by the
SAV. The oscillations consisted of applying a small-ampli-
tude volume perturbation at 3 Hz to the airway opening.
Measurements of piston volume displacement and cylinder
pressure were used to calculate the impedance of the respi-
ratory system from which respiratory system resistance val-
ues were derived.
Whole body plethysmography. We estimated total pulmo-
nary airflow in unrestrained conscious mice with a whole
body plethysmograph (Buxco Electronics, Troy, NY). Pres-
sure differences between a chamber containing the mice
and a reference chamber were used to extrapolate minute
volume, tidal volume, breathing frequency, and enhanced
paused (Penh). Penh is a dimensionless parameter that is
a function of total pulmonary airflow in mice during the
respiratory cycle. Penh is described by the equation
Penh  (PEP/PIP)  Pause; where PEP is the peak expi-
ratory pressure, PIP is the peak inspiratory pressure, and
Pause is a component of expiration time. This parameter is
dependent on the breathing pattern of the mice and was
also shown to correlate with airway resistance as mea-
sured by traditional invasive techniques on ventilated
mice (15).
Lung histology. We obtained lung tissue for histological
analysis by instilling 1 ml of 10% neutral-buffered formalin
(30 cmH2O constant pressure) through a cannula inserted
into the trachea. After instillation of fixative, the trachea was
ligated, and the excised lung was immersed in formalin for
24 h (at 4°C). Two nonconsecutive parasaggital sections (5
m) were obtained from paraffin-embedded tissue, stained
with hematoxylin and eosin, and analyzed by bright-field
microscopy (n  5 mice per group).
Antigen sensitization and challenge. Mice (6–8 wk) were
sensitized by an intraperitoneal injection (100 l) of 20 g of
chicken ovalbumin (OVA; Sigma, St. Louis, MO) emulsified
in 2 mg of Imject Alum [Al(OH)3/Mg(OH)2; Pierce, Rockfield,
IL] on days 0 and 14. Mice were subsequently challenged
with an aerosol generated from 1% OVA in saline or saline
alone for 20 min by ultrasonic nebulization (DeVilbiss) on
days 24, 25, and 26. Assessments of airway responsiveness
were made on day 28.
Statistical analysis. Data presented are the means  SE.
Statistical analysis was performed on parametric data using
t-tests with differences between means considered significant
when P  0.05.
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RESULTS
Tracheal airway smooth muscle from Gq/ mice
are hyporesponsive to MCh ex vivo. Isometric force
generation assessments of tracheal smooth muscle in
response to 50 mM KCl (i.e., depolarized maximal
contraction) showed that no intrinsic differences exist
between wild-type and Gq/ mice regarding the ca-
pacity of these tissues to constrict (Table 1). However,
MCh dose-response curves revealed that the tracheas
isolated from Gq/ mice were hyporeactive relative
to wild type (Table 1 and Fig. 1A). This response was
similar when plotted either as percent maximum re-
sponse to MCh or as a percentage of maximum KCl
response. Despite this shift in responsiveness, the ten-
sion generated in response to high doses of MCh by
Gq/ tracheas reached a plateau similar to wild-type
tracheas (Table 1). Western blot analysis of the protein
from the tracheal preparations confirmed that the
knockout mice did not express Gq. Moreover, these
data demonstrated that the expression level of another
subfamily member, G11, was significant in the tra-
chea of wild-type and Gq/ mice and was unaffected
by the loss of Gq (Fig. 1B).
Gq/ mice are hyporesponsive to cholinergic stim-
uli in vivo. The consequences of altered smooth muscle
responses were further examined in vivo by invasive
measurements of airway resistance and whole body
plethysmography. The lung mechanics of the Gq/
mice differed significantly from wild-type littermates
in response to MCh administration (Fig. 2). Lung re-
sistance induced by MCh was minimally affected in
Gq/ mice by even the highest doses of MCh (50–100
mg/ml). Similar airway responses to inhaled MCh and
serotonin (an agonist that acts presynaptically to in-
duce acetylcholine release) were observed in these mice
by whole body plethysmography. Gq/ mice exhib-
ited minimal reactivity to MCh regardless of the dose
applied (Fig. 3A) and no significant reactivity to sero-
tonin even at doses that resulted in maximum reactiv-
ity of wild-type mice (Fig. 3B).
Airway morphology of Gq/ mice is indistinguish-
able from wild-type mice. Microscopic examination of
the lungs from wild-type and Gq/ mice revealed no
obvious differences between the two groups (Fig. 4, A
and B).
Gq/ mice fail to exhibit airway reactivity to MCh
in a model of allergen-induced AHR. Airway reactivity
of OVA-sensitized/aerosol-challenged Gq-deficient mice
following provocation with MCh was examined by
whole body plethysmography to determine whether
Gq-mediated signaling is also required for the devel-
opment of allergen-mediated AHR. In contrast to OVA
sensitization/aerosol challenge of wild-type mice,
which leads to a significant increase in airway obstruc-
tion (i.e., Penh levels) relative to control mice chal-
lenged with saline only, Gq/ mice challenged with
OVA did not demonstrate an increase in Penh com-
pared with a Gq/ control group challenged with
saline only (Fig. 5). It is noteworthy that in addition to
this failure to develop AHR to MCh, neither group of
Gq mice (i.e., saline or OVA treated) had a significant
dose-dependent response to MCh relative to saline-
treated control wild-type animals.
DISCUSSION
The provocative conclusion derived from the data
presented is that signaling pathways mediated by the
heterotrimeric G protein Gq are critical in the control of
airway function in response to cholinergic receptor
activation, potentially through effects on airway
smooth muscle contraction. These effects appear to be
complex, as tracheal tension measurements of Gq/
mice differed quantitatively and qualitatively from the
effects observed in whole animal experiments. Specifi-
cally, the effects of MCh on tracheal rings appear to be
less pronounced compared with the in vivo assess-
ments. The reasons for this discrepancy are unclear;
however, several possible mechanisms may account for
the observed differences: 1) the resistance to airflow is
inversely proportional to the fourth power of the radius
of the airway (26). Therefore, small changes observed
in airway smooth muscle shortening (tracheal tension)
will be magnified in the in vivo measurements, because
radius is the most important determinant of the resis-
tance to airflow (e.g., decreasing the radius of an air-
way by half will increase the resistance to flow 16-fold).
2) The differences observed between these two assess-
ments of smooth muscle contraction may reflect differ-
ences in the contributions of different airway genera-
tions and differences in Gq-coupled receptor distribu-
tion along these airways. The airways that primarily
contribute to the pressure changes measured in the in
vivo experiments are thought to be the midsized and
smaller-diameter intrapulmonary airways (i.e., not the
trachea) (24). This hypothesis is supported by observed
differences in muscarinic receptor density and distri-
bution observed throughout the airways. Emala and
colleagues (10) have shown that M2 receptors are the
predominant receptor in the trachea and that they
continually diminish in density in the bronchi and
peripheral lung, whereas the M3 receptor is present at
[1/10] the density of M2, but the relative density of
the M3 increases continually (compared to the M2
receptor) in the bronchi and peripheral lung. 3) It is
possible that other cell types besides smooth muscle
may represent a significant component of the signaling
process involved in airway smooth muscle contraction.
Airway responsiveness in response to a cholinergic
receptor such as MCh is a complex phenotype influ-
Table 1. Active tension (g) generated in response
to KCl and methacholine
Wild Type Gq/
KCl, 50 mM 0.840.09 0.810.08
Methacholine, 104 M 2.120.09 2.140.11
EC50, M 0.310.05 0.670.07*
Values are means  SE (n  10–12 mice per group). Gq/, gene
knockout mice deficient in the -subunit of Gq. *Significantly differ-
ent (P  0.05) from wild-type mice.
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enced by several cell types in the airways, including
smooth muscle, neurons, epithelial cells, and endothe-
lial cells (1, 2, 5). M1 muscarinic receptors are coupled
to the Gq family (6) and are located on postganglionic
neurons that contribute to bronchoconstriction by pos-
itively regulating depolarization and cholinergic neu-
rotransmission (20). However, specific inhibition of M1
receptor activation with pirenzipine does not block the
effects of inhaled MCh (20), suggesting that this mech-
anism is not responsible for the different effects ob-
served in the in vitro and in vivo experiments. Addi-
tionally, epithelial cells and endothelial cells respond
to M3 receptor stimulation by generating nitric oxide,
which may play an important role in bronchodilation
(2). It is more difficult to speculate on how Gq deletion
in these cells would lead to a hyporesponsive pheno-
type in naive mice, but, without additional data, the
contribution of these cells to the observed phenotype
cannot be excluded.
Fig. 1. Tracheas isolated from Gq-deficient mice are
hyporesponsive to methacholine (MCh). A: active ten-
sion generated in response to increasing doses of MCh
is plotted as the percentage of maximum response gen-
erated by MCh. Values presented are means  SE (n 
10–12 mice/group). *Significantly different (P  0.05)
from wild-type (WT) mice. B: Western blot analyses of
proteins isolated from the trachea of WT and Gq-
deficient (Gq/) mice. Antisera are specific for the
indicated -subunit except for the anti-Gq/11, which
recognizes both proteins. Molecular mass of Gq and
G11 is 42 kDa.
Fig. 2. Lung resistance in Gq-deficient mice is attenuated following
administration of MCh. Lung resistance (RL) values were obtained
by a forced oscillation technique. Airway reactivity is plotted as a
function of increasing doses of inhaled MCh. Values presented are
means  SE (n  10–12 mice/group). *Significantly different (P 
0.05) from WT mice.
Fig. 3. Gq-deficient mice are hyporesponsive to inhaled MCh and
serotonin. Airway reactivity [enhanced pause (Penh)] of each group
is plotted as a function of increasing doses of inhaled MCh (A) or
serotonin (B). Values presented are means  SE (n  9–14 mice/
group). *Significantly different (P  0.05) from WT mice.
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The involvement of nonairway smooth muscle cell
types in the regulation of airway responsiveness may
be particularly relevant to the loss of AHR in sensi-
tized/challenged Gq/ mice. AHR development in
this model is incompletely understood, but there are
data to support the involvement of Th2 inflammatory
responses, including the production of cytokines and
leukotrienes and the infiltration of the pulmonary pa-
renchyma by activated T lymphocytes and eosinophils
(22, 41). The relative importance of the recruitment
and activation of these leukocytes is difficult to assess,
as the magnitude of the leukocyte infiltrate is a poor
prognostic indicator for the development of AHR (3, 17,
36). Nonetheless, we have previously reported that
OVA-treated Gq/ mice exhibit an 67% reduction
in airway inflammation and a concurrent decrease in
pulmonary eosinophilia without a decrease in Th2 cy-
tokine production or T cell activation (4), suggesting
that the loss of lung eosinophils may contribute to the
failure of OVA-treated Gq/ mice to develop AHR.
This inflammation-dependent contribution, however,
is likely to be modulatory and not directly responsible
for the failure of these mice to react following MCh
provocation, as saline control Gq/ mice (i.e., ani-
mals with little to no pulmonary eosinophil infiltrate)
also failed to display significant dose-dependent reac-
tions to this cholinergic receptor agonist.
It is noteworthy that any interpretations of these
data are necessarily complicated by the fact that these
signals do not function in isolation. That is, several G
proteins are expressed in each of the potentially rele-
vant cell types, and a degree of promiscuity exists
regarding G protein receptor coupling. For example,
signaling through M3 and thromboxane A2 activates
both Gq and G12 to mediate distinct effects in response
to the same agonist (19, 33). Also, evidence for simul-
taneous coupling to G proteins with opposing effects, Gi
and Gs, has been clearly demonstrated for the 2-
adrenergic receptor (7) and 	2-adrenergic receptor (42)
in mammalian hearts. The 	2-adrenergic receptor has
also been shown to similarly activate two members of
the Gi family, Gi2 and Gi3 (42). Moreover, tissues are
constantly exposed to and stimulated by agonists that
signal through other G proteins and other signaling
mechanisms (e.g., tyrosine kinases).
Seemingly conflicting data exist in the literature
concerning the function of G proteins studied by vari-
ous techniques and in various cell types. It has been
suggested that a functional overlap exists between Gq
and G11 on the basis of experiments in double knockout
mice (31). These studies demonstrate that homozygous
deficiency at both alleles results in embryonic lethality,
that expression of a just single copy of the four alleles
results in death within 1 h after birth, and that at least
two alleles of the four contributed by these two genes
are required for survival after birth. The conclusionFig. 4. Airway morphology of Gq-deficient mice is indistinguishablefrom WT mice. Structure of the airways and surrounding tissue
within the lungs was visualized by light microscopy of hematoxylin-
eosin-stained tissue sections of WT (A) and Gq/ (B) mice. Pho-
tomicrographs are representative of 5 mice/group. Bar, 50 m.
Fig. 5. Allergen-induced airway hyperreactivity does not develop in
Gq/ mice. WT and Gq/ mice were sensitized and aerosol
challenged with ovalbumin (OVA). Airway reactivity to increasing
doses of MCh was determined 48 h after the last of 3 OVA challenges.
Values presented are means  SE (n  9–12 mice/group). *Signifi-
cantly different (P  0.05) from WT mice. SAL, saline.
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from these data was that Gq and G11 can functionally
compensate for each other during development (31).
Subsequently, mice with conditionally inactivated Gq
on a G11-deficient background have been used to dem-
onstrate that these two proteins are critical in the
development of myocardial hypertrophy in adults (38).
Evidence for promiscuous coupling of Gq and G11 to
effector proteins that activate calcium release has been
shown in pancreatic and submandibular gland cells in
vitro (43), whereas evidence for distinct roles for Gq
and G11 has been shown in fibroblasts (44), neurons
(14), and portal vein myocytes (25). Interestingly,
Western blot analyses demonstrate that a genetic de-
ficiency in Gq has no significant effect on the expres-
sion levels of the other G protein (G11). These obser-
vations suggest that the results presented can be at-
tributed to the loss of Gq signaling and are not a
simple consequence of differential G protein expres-
sion/usage in airway smooth muscle, although poten-
tial effects of G protein deletion on the complex balance
of integrated signaling that occurs in any cell type
cannot be ruled out.
Mouse models of human airway disease are increas-
ingly and successfully used in laboratory investiga-
tions because of the nominal costs associated with
small animals, the similarity of the genomes, and the
ease of genetic manipulation. However, there are some
limitations to their use and the interpretations of the
data derived from experiments on mice. Although the
structural components are similar between the two
species, obvious differences between human and mouse
airways in size and morphology may contribute to
differences in airway reactivity to various agonists.
Also, differences in the reactivity to certain agonists
likely arise from differences in receptor expression and
utilization. For example, serotonin may have direct
and indirect effects on airway smooth muscle respon-
siveness in some species but affects only neural path-
ways in the mouse (23). This effect is also seen in the
present study, as serotonin has potent effects on Penh
(with neural component) but does not affect the re-
sponse of mouse trachea ex vivo (without neural com-
ponent).
The mechanisms leading to the development of air-
way dysfunction in pulmonary diseases are likely to be
combinatorial, involving alterations in receptor func-
tion, smooth muscle electrophysiology, airway mor-
phology/geometry, airway caliber, airway inflamma-
tion, and epithelial damage. The loss of allergen-in-
duced AHR in Gq/ mice suggests that the
intracellular signaling pathways mediated by Gq are
required in one or more of these mechanisms. Further-
more, the demonstration of an effect on airway reac-
tivity in naive Gq/ mice implies that Gq signaling
directly in airway smooth muscle (e.g., muscarinic re-
ceptor signaling) is likely to be critical. The significance
of these findings to human health resides in the iden-
tification of Gq as a potential target that mediates
bronchodilation in airway diseases by regulating both
baseline responsiveness and inflammatory-mediated
contraction of parasympathetic neuromuscular activity
in the airways. Airway inflammation increases the
level of bronchomotor tone in both asthma (34) and
COPD (12) patients, each of which, as the data pre-
sented here would predict, benefits from the adminis-
tration of anticholinergic agents. However, currently
available anticholinergic agents inhibit all three mus-
carinic receptors that have a role in airway function
(i.e., M1, M2, and M3). Strategies targeting Gq thus
represent novel therapeutic modalities to regulate air-
way reactivity.
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